The scientific rationale for stem cell therapy in autism focuses on addressing neuroinflammation, immune dysregulation, and reduced brain blood flow. Mesenchymal stem cells (MSCs) release anti-inflammatory cytokines and growth factors to potentially calm overactive microglia and support neural connectivity through paracrine signaling.
- Immunomodulation: MSCs secrete proteins to regulate immune responses and decrease chronic brain inflammation.
- Angiogenesis: Cells like CD34+ stimulate new blood vessel growth to improve brain oxygenation.
- Synaptic repair: Secreted molecules may trigger neuroplasticity and repair disrupted neural network connections.
- Cellular signaling: Exosomes act as messengers to trigger self-repair and reduce localized oxidative stress.
Bookimed Expert Insight: While basic packages focus on 50 million cells, clinics like Stem Solutions and Aura Regenerative Center often incorporate exosome-based protocols to bypass the blood-brain barrier. Data shows that practitioners like Dr. Anna Lara, with 1,100+ cases, prioritize high-cell counts of 100 million for complex neurological profiles.
Patient Consensus: Many families report practical improvements such as better sleep, increased eye contact, and calmer behavior. However, they emphasize that these changes are often gradual and should complement established speech and occupational therapies.